Holen Sie sich die Stockscreener-App
7.215
3.57%
-0.205
Schlusskurs vom Vortag:
$7.42
Offen:
$7.58
24-Stunden-Volumen:
10,099
Relative Volume:
0.15
Marktkapitalisierung:
$18.13M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.74M
KGV:
-0.6826
EPS:
-10.5698
Netto-Cashflow:
$-9.50M
1W Leistung:
-10.00%
1M Leistung:
+14.39%
6M Leistung:
+23.25%
1J Leistung:
-87.69%
1-Tages-Spanne:
$7.11
$7.58
1-Wochen-Bereich:
$7.11
$7.96
52-Wochen-Spanne:
$4.6325
$62.49
Intensity Therapeutics Inc Stock (INTS) Company Profile
Firmenname
Intensity Therapeutics Inc
Sektor
Branche
Telefon
203-221-7381
Adresse
1 ENTERPRISE DRIVE, SUITE 430, SHELTON
Compare INTS vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INTS
Intensity Therapeutics Inc
|
7.1548 | 18.80M | 0 | -11.74M | -9.50M | -10.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.52 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
746.24 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
705.10 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
312.69 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.42 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Intensity Therapeutics Inc Aktie (INTS) Neueste Nachrichten
Intensity Therapeutics price target adjusted to $30 at Alliance Global - TipRanks
Intensity Therapeutics Updates Breast Cancer Trial, Files To Resume Enrollment Following Study Pause - Sahm
Intensity Therapeutics reports early trial data in breast cancer - Investing.com South Africa
Intensity Therapeutics provides update on INVINCIBLE-4 Study - TipRanks
Ballard Reports Q4 2025 and Full Year Results - Weekly Voice
Intensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study - PR Newswire
Bear Alert: Is Intensity Therapeutics Inc likely to announce a buyback2026 Intraday Action & Growth Focused Investment Plans - baoquankhu1.vn
Take Profit: Should I set a stop loss on Intensity Therapeutics Inc2026 Outlook & Safe Entry Point Identification - baoquankhu1.vn
Intensity Therapeutics regains Nasdaq compliance - Investing.com Nigeria
Investment Review: Can Intensity Therapeutics Inc disrupt its industryQuarterly Earnings Report & Daily Oversold Bounce Ideas - baoquankhu1.vn
What's going on with Intensity Therapeutics stock Friday? - MSN
Intensity Therapeutics regains Nasdaq compliance By Investing.com - Investing.com Canada
CT biotech firm regains Nasdaq compliance after carrying out reverse-stock split - Hartford Business Journal
Intensity Therapeutics Regains Nasdaq Compliance, Stabilizing Market Listing - TipRanks
Intensity Therapeutics regains compliance with Nasdaq's minimum bid price requirement - marketscreener.com
Intensity Therapeutics Regains Compliance with Nasdaq's Minimum Bid Price Requirement - PR Newswire
Why Is Retail Going Gaga Over INTS Stocks Today? - Stocktwits
INTS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Intensity Therapeutics Announces Reverse Stock Split - 富途牛牛
Swing Trade: Whats next for Intensity Therapeutics Inc stockPortfolio Return Summary & Verified Chart Pattern Signals - baoquankhu1.vn
Retail Trends: Is Intensity Therapeutics Inc stock influenced by commodity pricesJuly 2025 Setups & Daily Profit Focused Screening - baoquankhu1.vn
INTS.O Technical Analysis & Stock Price Forecast - Intellectia AI
VTVT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
INTS Should I Buy - Intellectia AI
INTS.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
INTS.O Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
INTS.O PE Ratio & Valuation, Is INTS.O Overvalued - Intellectia AI
Intensity Therapeutics (INTS) Price Target Increased by 2,399.98% to 74.38 - Nasdaq
Surprises Report: Whats next for Intensity Therapeutics Inc stock2025 Retail Activity & Free Community Consensus Stock Picks - baoquankhu1.vn
Aug Mood: Is Intensity Therapeutics Inc stock forming a cup and handleJuly 2025 Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Buy Signal: Should I set a stop loss on Intensity Therapeutics IncJuly 2025 Earnings & Accurate Buy Signal Alerts - baoquankhu1.vn
Sentiment Watch: Can MAAS deliver alphaWeekly Risk Summary & Weekly High Potential Alerts - baoquankhu1.vn
Intensity Therapeutics Inc Share Price USD0.0001 - Hargreaves Lansdown
How Intensity Therapeutics Inc. stock compares to market leadersJuly 2025 Pullbacks & Fast Gain Swing Trade Alerts - mfd.ru
Can Intensity Therapeutics Inc. stock beat market expectations this quarterWeekly Trade Analysis & Low Risk Investment Opportunities - mfd.ru
Is Intensity Therapeutics Inc.’s growth already priced inQuarterly Market Review & AI Enhanced Trading Signals - mfd.ru
Why did INTS stock plummet 25% today? - MSN
Why did INTS stock plummet 30% pre-market today? - MSN
CT biotech firm plans reverse stock split to regain Nasdaq compliance - Hartford Business Journal
Intensity Therapeutics Highlights 2025 Milestones and Outlines 2026 Strategic Priorities - Weekly Voice
Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results - Intellectia AI
Can Intensity Therapeutics Inc. disrupt its industryPortfolio Risk Report & Free Community Consensus Stock Picks - mfd.ru
Why Did INTS Stock Plummet 25% Today? - Stocktwits
Growth Review: Can Intensity Therapeutics Inc benefit from deglobalizationQuarterly Profit Review & Free Reliable Trade Execution Plans - baoquankhu1.vn
Intensity Therapeutics announces 1-for-25 reverse stock split By Investing.com - Investing.com Australia
Intensity Therapeutics Announces 1-for-25 Reverse Stock Split - TipRanks
Intensity Therapeutics (Nasdaq: INTS) Stock: Announces 1-for-25 Reverse Split to Meet Nasdaq Rule - CoinCentral
What's Going On With Intensity Therapeutics Stock Friday? - Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Intensity Therapeutics announces 1-for-25 reverse stock split - Investing.com
Intensity Therapeutics announces reverse stock split - marketscreener.com
Finanzdaten der Intensity Therapeutics Inc-Aktie (INTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):